DF
BIIB icon

Dunhill Financial’s Biogen BIIB Stock Holding History

Dunhill Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43K Sell
6
-1
-14% -$191 ﹤0.01% 940
2026
Q1 		$1.34K Buy
7
+2
+40% +$369 ﹤0.01% 901
2025
Q4 		$893 Buy
5
+2
+67% +$327 ﹤0.01% 849
2025
Q3 		$422 Sell
3
-1
-25% -$135 ﹤0.01% 868
2025
Q2 		$627 Sell
4
-6
-60% -$748 ﹤0.01% 832
2025
Q1 		$1.39K Sell
10
-142
-93% -$20.3K ﹤0.01% 786
2024
Q4 		$23.3K Buy
152
+50
+49% +$8.43K 0.01% 262
2024
Q3 		$19.8K Buy
102
+15
+17% +$3.14K 0.01% 278
2024
Q2 		$20.1K Buy
87
+76
+691% +$16.5K 0.01% 212
2024
Q1 		$2.31K Sell
11
-12
-52% -$2.81K ﹤0.01% 466
2023
Q4 		$5.94K Buy
+23
New +$5.65K 0.01% 274

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dunhill Financial's BIIB Position: Q2 2026 in Review

Dunhill Financial reduced its Biogen (BIIB) stake by 14% in Q2 2026, selling an estimated $191 and leaving 6 shares worth $1.43K. The position accounts for ﹤0.01% of the portfolio, ranked #940.

Dunhill Financial first reported a position in BIIB in Q4 2023 and has held it in 11 quarters since. The position peaked at $23.3K in Q4 2024. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Dunhill Financial held 6 shares of Biogen worth $1.43K as of Q2 2026.
  • Dunhill Financial sold 1 Biogen share in Q2 2026, an estimated $191.
  • Biogen made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #940 holding.
  • Dunhill Financial first reported a position in Biogen in Q4 2023 and has held it in 11 quarters since.
  • Dunhill Financial's Biogen position peaked at $23.3K in Q4 2024.
  • 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.